Sleep Apnea
Implications in Cardiovascular and Cerebrovascular Disease
Herausgeber: Bradley, T Douglas; Floras, John S
Sleep Apnea
Implications in Cardiovascular and Cerebrovascular Disease
Herausgeber: Bradley, T Douglas; Floras, John S
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease specifically addresses the cardiovascular and cerebrovascular consequences of sleep apnea and is geared toward a broad readership of physicians that will ultimately aid patients suffering from sleep apnea.
Andere Kunden interessierten sich auch für
- Handbook of Sleep Disorders90,99 €
- Restless Legs Syndrome81,99 €
- Insomnia92,99 €
- Treatment of Pediatric Neurologic Disorders90,99 €
- Sleep Deprivation91,99 €
- Syncope115,99 €
- Sleep, Circadian Rhythms, and Metabolism76,99 €
-
-
-
Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease specifically addresses the cardiovascular and cerebrovascular consequences of sleep apnea and is geared toward a broad readership of physicians that will ultimately aid patients suffering from sleep apnea.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- 2nd edition
- Seitenzahl: 416
- Erscheinungstermin: 19. September 2019
- Englisch
- Abmessung: 229mm x 152mm x 20mm
- Gewicht: 386g
- ISBN-13: 9780367384906
- ISBN-10: 0367384906
- Artikelnr.: 57814541
- Herstellerkennzeichnung
- Produktsicherheitsverantwortliche/r
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Taylor & Francis Ltd (Sales)
- 2nd edition
- Seitenzahl: 416
- Erscheinungstermin: 19. September 2019
- Englisch
- Abmessung: 229mm x 152mm x 20mm
- Gewicht: 386g
- ISBN-13: 9780367384906
- ISBN-10: 0367384906
- Artikelnr.: 57814541
- Herstellerkennzeichnung
- Produktsicherheitsverantwortliche/r
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
T. Douglas Bradley, John S. Floras
Part I. Influence of Sleep and Respiration on the Cardiovascular System. 1.
Circadian variations in clock genes: implications for cardiovascular
disease. 2. Lower brainstem mechanisms of cardiorespiratory integration. 3.
Mechanical interactions between the respiratory and circulatory systems. 4.
Alterations in respiratory and cardiac activity during sleep onset. 5.
Physiological effects of sleep on the cardiovascular system. 6. Metabolic
effects of normal and disturbed sleep. 7. Oxidative stress, inflammation,
and vascular function in sleep apnea. 8. Obesity, leptin and sleep apnea.
Part II: Sleep Apnea and Hypertension. 9. Influence of sleep apnea on heart
rate and blood pressure regulation: implications for hypertension and
impaired heart rate variability. 10. Epidemiological evidence for an
association between sleep apnea, hypertension and cardiovascular disease.
11. Treatment of hypertension in sleep apnea. Part III: Sleep Apnea,
Ischemic Heart Disease, and Cerebrovascular Disease.12. Cardiac arrhythmias
and sleep apnea. 13. Sleep apnea and atherosclerosis. 14. Sleep apnea and
cerebrovascular disease. 15. Circadian variation in the incidence of
cardiovascular and cerebrovascular ischemic events. Part IV: Sleep Apnea
and Congestive Heart Failure. 16. Theoretical models of periodic breathing.
17. Pathophysiological interactions between sleep apnea and congestive
heart failure. 18. Prevalence and prognostic significance of obstructive
and central sleep apnea in heart failure. 19. Treatment of obstructive and
central sleep apnea in patients with heart failure.
Circadian variations in clock genes: implications for cardiovascular
disease. 2. Lower brainstem mechanisms of cardiorespiratory integration. 3.
Mechanical interactions between the respiratory and circulatory systems. 4.
Alterations in respiratory and cardiac activity during sleep onset. 5.
Physiological effects of sleep on the cardiovascular system. 6. Metabolic
effects of normal and disturbed sleep. 7. Oxidative stress, inflammation,
and vascular function in sleep apnea. 8. Obesity, leptin and sleep apnea.
Part II: Sleep Apnea and Hypertension. 9. Influence of sleep apnea on heart
rate and blood pressure regulation: implications for hypertension and
impaired heart rate variability. 10. Epidemiological evidence for an
association between sleep apnea, hypertension and cardiovascular disease.
11. Treatment of hypertension in sleep apnea. Part III: Sleep Apnea,
Ischemic Heart Disease, and Cerebrovascular Disease.12. Cardiac arrhythmias
and sleep apnea. 13. Sleep apnea and atherosclerosis. 14. Sleep apnea and
cerebrovascular disease. 15. Circadian variation in the incidence of
cardiovascular and cerebrovascular ischemic events. Part IV: Sleep Apnea
and Congestive Heart Failure. 16. Theoretical models of periodic breathing.
17. Pathophysiological interactions between sleep apnea and congestive
heart failure. 18. Prevalence and prognostic significance of obstructive
and central sleep apnea in heart failure. 19. Treatment of obstructive and
central sleep apnea in patients with heart failure.
Part I. Influence of Sleep and Respiration on the Cardiovascular System. 1.
Circadian variations in clock genes: implications for cardiovascular
disease. 2. Lower brainstem mechanisms of cardiorespiratory integration. 3.
Mechanical interactions between the respiratory and circulatory systems. 4.
Alterations in respiratory and cardiac activity during sleep onset. 5.
Physiological effects of sleep on the cardiovascular system. 6. Metabolic
effects of normal and disturbed sleep. 7. Oxidative stress, inflammation,
and vascular function in sleep apnea. 8. Obesity, leptin and sleep apnea.
Part II: Sleep Apnea and Hypertension. 9. Influence of sleep apnea on heart
rate and blood pressure regulation: implications for hypertension and
impaired heart rate variability. 10. Epidemiological evidence for an
association between sleep apnea, hypertension and cardiovascular disease.
11. Treatment of hypertension in sleep apnea. Part III: Sleep Apnea,
Ischemic Heart Disease, and Cerebrovascular Disease.12. Cardiac arrhythmias
and sleep apnea. 13. Sleep apnea and atherosclerosis. 14. Sleep apnea and
cerebrovascular disease. 15. Circadian variation in the incidence of
cardiovascular and cerebrovascular ischemic events. Part IV: Sleep Apnea
and Congestive Heart Failure. 16. Theoretical models of periodic breathing.
17. Pathophysiological interactions between sleep apnea and congestive
heart failure. 18. Prevalence and prognostic significance of obstructive
and central sleep apnea in heart failure. 19. Treatment of obstructive and
central sleep apnea in patients with heart failure.
Circadian variations in clock genes: implications for cardiovascular
disease. 2. Lower brainstem mechanisms of cardiorespiratory integration. 3.
Mechanical interactions between the respiratory and circulatory systems. 4.
Alterations in respiratory and cardiac activity during sleep onset. 5.
Physiological effects of sleep on the cardiovascular system. 6. Metabolic
effects of normal and disturbed sleep. 7. Oxidative stress, inflammation,
and vascular function in sleep apnea. 8. Obesity, leptin and sleep apnea.
Part II: Sleep Apnea and Hypertension. 9. Influence of sleep apnea on heart
rate and blood pressure regulation: implications for hypertension and
impaired heart rate variability. 10. Epidemiological evidence for an
association between sleep apnea, hypertension and cardiovascular disease.
11. Treatment of hypertension in sleep apnea. Part III: Sleep Apnea,
Ischemic Heart Disease, and Cerebrovascular Disease.12. Cardiac arrhythmias
and sleep apnea. 13. Sleep apnea and atherosclerosis. 14. Sleep apnea and
cerebrovascular disease. 15. Circadian variation in the incidence of
cardiovascular and cerebrovascular ischemic events. Part IV: Sleep Apnea
and Congestive Heart Failure. 16. Theoretical models of periodic breathing.
17. Pathophysiological interactions between sleep apnea and congestive
heart failure. 18. Prevalence and prognostic significance of obstructive
and central sleep apnea in heart failure. 19. Treatment of obstructive and
central sleep apnea in patients with heart failure.